home / stock / mdxg / mdxg news


MDXG News and Press, MiMedx Group Inc From 05/31/22

Stock Information

Company Name: MiMedx Group Inc
Stock Symbol: MDXG
Market: OTC
Website: mimedx.com

Menu

MDXG MDXG Quote MDXG Short MDXG News MDXG Articles MDXG Message Board
Get MDXG Alerts

News, Short Squeeze, Breakout and More Instantly...

MDXG - MIMEDX Receives $4.6 Million Award from the Department of Defense to Advance the Treatment of Combat Casualty Wounds and Burns

Funding Enables Evaluation of PURION ® Processed Placental Tissue as an Innovative Approach in the Management of Acute Military-Related Injuries, Addressing a Critical Unmet Need MARIETTA, Ga., May 31, 2022 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIME...

MDXG - Leading Independent Proxy Advisory Firm ISS Recommends that MIMEDX Shareholders Vote "FOR ALL" of the Company's Proposals

Follows Previous Recommendation from Glass Lewis in Support of ALL Proposals Recommends Shareholders Vote “FOR” Both of MIMEDX’s Highly Qualified Director Nominees – James L. Bierman and Phyllis Gardner, M.D. Recommends Shareholders Vote ...

MDXG - Leading Independent Proxy Advisory Firm Glass Lewis Recommends that MIMEDX Shareholders Vote "FOR ALL" of the Company's Proposals

Recommends Shareholders Vote “FOR” Both of MIMEDX’s Highly Qualified Director Nominees – James L. Bierman and Phyllis Gardner, M.D. Recommends Shareholders Vote “FOR” the Company’s Say-on-Pay Proposal MARIETTA, Ga., May 20, ...

MDXG - MIMEDX Investor Presentation Highlights Clear Strategy for Value Creation

Decisive, Positive Actions Taken to Stabilize and Transform MIMEDX Have Established Strong, New Foundation for Growth Company Urges Shareholders to Vote “FOR” Both Highly Qualified Director Nominees – James L. Bierman and Phyllis Gardner, M.D. –...

MDXG - Prescience Point Capital Management Calls on MiMedx to Confirm the Company Has Received Letters of Serious Concern from other Shareholders

Prescience Point Capital Management Calls on MiMedx to Confirm the Company Has Received Letters of Serious Concern from other Shareholders PR Newswire Disappointed that the MiMedx Board Has Resorted to Disinformation and Distortions to Distract Shareholders from the Bo...

MDXG - MIMEDX Mails Letter to Shareholders

Highlights Successful Execution of Transformation Strategy Under CEO Tim Wright Reaffirms Commitment to Enhancing Value for ALL Shareholders Urges Shareholders to Vote “FOR” Both of MIMEDX’s Highly Qualified Director Nominees – James L. Bier...

MDXG - MIMEDX Comments on Prescience Point's False and Misleading Statements

Cautions Shareholders Not to Let Prescience Point Unravel MIMEDX’s Transformation Urges Shareholders to Protect their Investments by Voting “FOR” Dr. Phyllis Gardner and James L. Bierman Highlights Prescience Point’s and Eiad Asbahi’s T...

MDXG - Prescience Point Capital Management Issues Open Letter to Shareholders of MiMedx Group

Prescience Point Capital Management Issues Open Letter to Shareholders of MiMedx Group PR Newswire Intends on Withholding Votes Against Directors Phyllis Gardner and James Bierman at 2022 Annual Meeting and Vote Against Approval of Executive Compensation ...

MDXG - MiMedx Group, Inc. (MDXG) CEO Tim Wright on Q1 2022 Results - Earnings Call Transcript

MiMedx Group, Inc. (MDXG) Q1 2022 Earnings Conference Call May 04, 2022, 08:30 AM ET Company Participants Jack Howarth - Senior Vice President, Investor Relations Tim Wright - Chief Executive Officer Pete Carlson - Chief Financial Officer Rohit Kashyap - Executive Vice President and Chief Com...

MDXG - MiMedx Group GAAP EPS of -$0.11 misses by $0.01, revenue of $58.89M beats by $4.79M

MiMedx Group press release (NASDAQ:MDXG): Q1 GAAP EPS of -$0.11 misses by $0.01. Revenue of $58.89M (-1.4% Y/Y) beats by $4.79M. For further details see: MiMedx Group GAAP EPS of -$0.11 misses by $0.01, revenue of $58.89M beats by $4.79M

Previous 10 Next 10